Does Pfizer Stock Ever Go Up?

Quote



Pfizer only makes other stocks go up by drastically overpaying to acquire them. then Pfizer eliminates any accumulative value of combining the organizations and makes it a net loss for PFE. The record doesn’t lie.

Pfizer leadership is touting the one year anniversary of closing Seagen. Former Seagen execs are counting their money and PFE is down over the 12 months. Around 31.50 March 2024 and now around 24.50. How is this worth 24MM and bonus double of target? Where is the value?
 




The pump and dump worked for covid products but they can’t get any traction pumping weight loss. It’s their only “strategy”.

BTW, is AB in the clinical trial for weight loss? Somebody get that guy a sandwich
 








Proxy adviser ISS recommends against Pfizer executive pay proposal.

Somebody has to send a strong message to the board that continuing to lower the bar doesn’t make a stronger company. Under $25 now.

Now that Sally’s month long vanity project on book reviews (Hey, look it me and all the people i know!!) has ended, perhaps she could read a few business books too. PFE is too far gone for “Good to Great” but maybe she could audiobook “What Got You Here Won’t Get You There” or “Execution The Discipline Of Getting Things Done”
 


Under $25 is an absolute disgrace. PFE’s market cap is shrinking by the day. How Bourla is still the captain of this sinking ship is beyond anyone’s comprehension.
 




anonymous said:
Yes, feed it the Blue Pill and it goes up for 4 hours. Then Sell, Sell, Sell
Click to expand...
Unfortunately, I think they gave PFE the weight loss drug instead. In a short trial, PFE lost 35% of the company value. There is an awful side effect that the loss in value has continued and the only probable remedy is to fire AB and all the rest of the sorry lot that got us here.

Fire ‘em, break it up, sell the pieces. This turd will never float on top again
 






Jon Donebros got a standing ovation for his magic shtick at the meeting in Orlando. Maybe he can give Albert a few pointers that he can use at the upcoming annual shareholder meeting. Albert can throw out a few magic tricks to show how he made 60% of PFE value disappear!
 




Pfizer has been in a precarious situation since the Lipitor loss of exclusivety. Remember the Pfizer/ Allergan merger? Covid vaccine was a success but at the base of it all the company has had bad management. There is a considerable amount of arrogance combined with ineptitude. As long as that culture remains, there will be no improvement.
 




anonymous said:
Pfizer has been in a precarious situation since the Lipitor loss of exclusivety. Remember the Pfizer/ Allergan merger? Covid vaccine was a success but at the base of it all the company has had bad management. There is a considerable amount of arrogance combined with ineptitude. As long as that culture remains, there will be no improvement.
Click to expand...
100% true. Inept leadership is the #1 reason that our stock has (pretty much) been stagnant for two decades
 


anonymous said:
Pfizer has been in a precarious situation since the Lipitor loss of exclusivety. Remember the Pfizer/ Allergan merger? Covid vaccine was a success but at the base of it all the company has had bad management. There is a considerable amount of arrogance combined with ineptitude. As long as that culture remains, there will be no improvement.
Click to expand...
I cannot consider Pfizer’s handling of the covid vaccine a success. I will leave the safety debates to others and focus on two other major failures. Both of these failures could be business school and public health / public policy case studies for decades.

1). Public health and policy: Pfizer leadership did not control the message, the resulting narrative or set an understanding for a new type (mRNA) vaccine. Pfizer allowed incorrect messaging about efficacy, herd and “protecting others” to run rampant. HCPs were not informed or prepared to answer questions about MOA so patients found their answer of choice in the internet cesspool. Subsequent mRNA vaccines now have a steep hill of trust to climb and it is a slippery slope that Pfizer created. The future promise of mRNA vaccination is tarnished, if not compromised.
2). Financial: Pfizer sold billions in a product and market that did not exist in the forecast. Yet even with billions pouring in, Pfizer became less and less connected to reality in every new forecast while squandering newfound revenue on something (maybe acquisitions?) that have produced no accretive value. In the future, before the next pandemic comes, academics will tear apart the bone headed decisions that reduced company value and reputation during a period when both could have soared
 


anonymous said:
I cannot consider Pfizer’s handling of the covid vaccine a success. I will leave the safety debates to others and focus on two other major failures. Both of these failures could be business school and public health / public policy case studies for decades.

1). Public health and policy: Pfizer leadership did not control the message, the resulting narrative or set an understanding for a new type (mRNA) vaccine. Pfizer allowed incorrect messaging about efficacy, herd and “protecting others” to run rampant. HCPs were not informed or prepared to answer questions about MOA so patients found their answer of choice in the internet cesspool. Subsequent mRNA vaccines now have a steep hill of trust to climb and it is a slippery slope that Pfizer created. The future promise of mRNA vaccination is tarnished, if not compromised.
2). Financial: Pfizer sold billions in a product and market that did not exist in the forecast. Yet even with billions pouring in, Pfizer became less and less connected to reality in every new forecast while squandering newfound revenue on something (maybe acquisitions?) that have produced no accretive value. In the future, before the next pandemic comes, academics will tear apart the bone headed decisions that reduced company value and reputation during a period when both could have soared
Click to expand...
both correct
 



Write your reply...
Top Bottom
Back
Quote